Alunbrig | Brigatinib Tablet while Breastfeeding
Modern medicine has evolved so much so that sooner or later every breastfeeding mother needs to take it in one form or other. Medication that is present in mothers blood will transfer into her breast milk to some extent. Most drugs do so at low levels and pose no real risk to infants but then there are some exceptions. In This post will discuss whether Alunbrig | Brigatinib Tablet is safe in breast-feeding or not.

What is Alunbrig | Brigatinib Tablet used for?


ALUNBRIG is indicated for the treatment of patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) who have progressed on or are intolerant to crizotinib. This indication is approved under accelerated approval based on tumor response rate and duration of response [see Clinical Studies (14)]. Continued approval for this indication may be contingent upon verification and description of clinical benefit in a confirmatory trial. ALUNBRIG is a kinase inhibitor indicated for the treatment of patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) who have progressed on or are intolerant to crizotinib. This indication is approved under accelerated approval based on tumor response rate and duration of response. Continued approval for this indication may be contingent upon verification and description of clinical benefit in a confirmatory trial. (1)

I am breastfeeding mother and I am using Alunbrig | Brigatinib Tablet. Can it have any bad effect on my kid? Shall I search for better alternative?

Alunbrig | Brigatinib Tablet contains Brigatinib as active ingredients, . We do not have safety rating of Brigatinib but we do have analysis of Brigatinib, which is used in manufacturing of Alunbrig | Brigatinib Tablet. You can get a good idea about Alunbrig | Brigatinib Tablet usage while breastfeeding by going through our detailed analysis as below.

Alunbrig | Brigatinib Tablet Breastfeeding Analsys


Brigatinib while Breastfeeding

CAS Number: 1197953-54-0

No information is available on the clinical use of brigatinib during breastfeeding. The manufacturer recommends that breastfeeding be discontinued during brigatinib therapy and for 1 week after the final dose.

Is Alunbrig | Brigatinib Tablet safe while breastfeeding

I am nursing mother and I have already used Alunbrig | Brigatinib Tablet, what should I do?

We are not completely sure about safety of Alunbrig | Brigatinib Tablet in breastfeeding. We would suggest you to contact your doctor or health care provider and explain your situation with Alunbrig | Brigatinib Tablet. If you observe anything abnormal with your baby please call 911 or contact emergency services in your area.


I am nursing mother and my doctor has suggested me to use Alunbrig | Brigatinib Tablet, is it safe?

If your doctor considers Alunbrig | Brigatinib Tablet safe enough to prescribe for you that means its benefits outweigh its known risks.


If I am using Alunbrig | Brigatinib Tablet, will my baby need extra monitoring?

Not Sure, Please check with your doctor or lactation consultant.


Who can I talk to if I have questions about usage of Alunbrig | Brigatinib Tablet in breastfeeding?

US
National Womens Health and Breastfeeding Helpline: 800-994-9662 (TDD 888-220-5446) 9 a.m. and 6 p.m. ET, Monday through Friday

UK
National Breastfeeding Helpline: 0300-100-0212 9.30am to 9.30pm, daily
Association of Breastfeeding Mothers: 0300-330-5453
La Leche League: 0345-120-2918
The Breastfeeding Network supporter line in Bengali and Sylheti: 0300-456-2421
National Childbirth Trust (NCT): 0300-330-0700

Australia
National Breastfeeding Helpline: 1800-686-268 24 hours a day, 7 days a week

Canada
Telehealth Ontario for breastfeeding: 1-866-797-0000 24 hours a day, 7 days a week